ANTHEM vs INDSWFTLTD: Stock Comparison

Anthem Biosciences Limited vs Ind-Swift Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Anthem Biosciences Limited shows a higher dividend yield, faster revenue growth and a higher ROCE, while Ind-Swift Limited shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anthem Biosciences Limited and Ind-Swift Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANTHEM is more favourable on 7 of 9 scored metrics and INDSWFTLTD on 2These counts are context-free and are not an overall rating.

Key Differences

EPS
ANTHEM has higher earnings per share
₹10.13 vs ₹0
Dividend Yield
ANTHEM has a higher dividend yield
0.25% vs 0%
Revenue Growth (TTM YoY)
ANTHEM has faster revenue growth
26.4% vs 0%
EPS Growth (TTM YoY)
ANTHEM has faster EPS growth
127.2% vs 0%
Qtr Sales Growth
ANTHEM has stronger quarterly sales growth
26.4% vs 0%
Qtr Profit Growth
ANTHEM has stronger quarterly profit growth
129% vs 0%
ROCE
ANTHEM has a higher ROCE
30.4% vs 13.4%
Net Margin
INDSWFTLTD has a higher net margin
55.01% vs 26.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANTHEMINDSWFTLTD
SectorHealthcareHealthcare
IndustryBiotechnologyPharmaceuticals

Price

MetricANTHEMINDSWFTLTD
Live Price₹769.9₹15.76
Day Change-1.02%6.13%
Volume2.43 L6.45 L
52-Week High₹873.5₹17.82
52-Week Low₹579.15₹14.71
Distance from 52W High-11.86%-11.56%

Valuation

MetricANTHEMINDSWFTLTD
Market Cap₹43,398 Cr₹0 Cr
P/E Ratio75.11x
P/B Ratio14.22x
EPS₹10.13₹0
Book Value₹54.17₹-122
Dividend Yield0.25%0%

Growth

MetricANTHEMINDSWFTLTD
Revenue Growth (TTM YoY)26.4%0%
EPS Growth (TTM YoY)127.2%0%
Qtr Sales Growth26.4%0%
Qtr Profit Growth129%0%

Profitability & Leverage

MetricANTHEMINDSWFTLTD
ROE22.3%
ROCE30.4%13.4%
Net Margin26.05%55.01%
Operating Margin39.3%63.48%
Debt to Equity0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricANTHEMINDSWFTLTD
Promoter Holding71.42% 3.26 pp55.58%
FII Holding2.58% 1.3 pp0%
DII Holding13.48% 1.93 pp0%
Public Holding12.53% 0.03 pp44.42%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anthem Biosciences Limited and Ind-Swift Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.